Company Filing History:
Years Active: 2018
Title: Vikas Duhan: Innovator in Immunotherapy
Introduction
Vikas Duhan is a prominent inventor based in Essen, Germany. He has made significant contributions to the field of immunotherapy, particularly through his innovative research and development of antibodies.
Latest Patents
Vikas Duhan holds a patent for an immunostimulatory anti-CEACAM1 antibody. This patent includes at least one antibody heavy chain (V) domain with antigen binding sites CDR1, CDR2, and CDR3. Additionally, it features at least one antibody light chain (V) domain with the same antigen binding sites. Notably, the antigen binding site CDR2 has a sequence homology of at least 80% to the amino acid sequence WINTYTGEPT (SEQ ID No. 21). He has 1 patent to his name.
Career Highlights
Vikas Duhan is affiliated with the University of Duisburg-Essen, where he conducts his research. His work focuses on advancing the understanding and application of immunostimulatory antibodies in medical treatments.
Collaborations
Some of his notable coworkers include Karl Lang and Bernhard Singer, who contribute to his research endeavors.
Conclusion
Vikas Duhan's innovative work in the field of immunotherapy highlights his role as a key inventor in advancing medical science. His contributions are paving the way for new therapeutic approaches.